$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Correct use of EIKANCE 0.01% atropine sulfate eye drops and medication guidance for children and adults
2026-02-01 22:25:32
Check Details
A complete description of the six-month liver function changes and safety monitoring plan for long-term use of Pretomanid
2026-02-01 22:25:32
Check Details
The role, efficacy and side effects of voclosporin, and patients’ real experience sharing
2026-02-01 22:25:32
Check Details
A complete description of the price of a box of ponatinib in India, channels for imported drugs, and precautions for use
2026-02-01 22:25:32
Check Details
Detailed description of common side effects and long-term use risks of safinamide mesylate tablets (Siddaco)
2026-02-01 22:25:32
Check Details
Tarlatamab (Tarlatamab) - What is Imdelltra, its pharmacological effects, indications and full explanation of use
2026-02-01 22:25:32
Check Details
Comparison of the effects and clinical application analysis of telisotuzumab-EMRELIS and CAR-T therapy
2026-02-01 22:25:32
Check Details
Where can you buy tovorafenib in China? Regular drug purchase channels and purchase precautions
2026-02-01 22:25:32
Check Details
Analysis of vorasidenib-VORANIGO side effects and long-term use safety, risks and precautions
2026-02-01 22:25:32
Check Details
Whether Zongatinib (Zongatinib) has been included in medical insurance and reimbursement policies and patient cost analysis
2026-02-01 22:25:32
Check Details
The synthesis principle, drug structure and research and development background of vosoritide
2026-02-01 22:25:32
Check Details
Analysis of the reasons and mechanism of sleep improvement after taking methylcobalamin injection (Rozebalamin)
2026-02-01 22:25:32
Check Details
1
2
...
2426
2427
2428
2429
2430
2431
2432
...
10228
10229
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Cemiplimab: A PD-1 Checkpoint Inhibitor for Skin Cancers and Non-Small Cell Lung Cancer
2
Nintedanib: A Multi-Target Antifibrotic Agent for Slowing Pulmonary Fibrosis Progression
3
Capmatinib (Tabrecta): Generational Positioning, Adverse Effect Incidence, and Comprehensive Management
4
Gilteritinib (XOSPATA): Dosing Cycle, Treatment Duration, and Development Background
5
Dabrafenib (TAFINLAR): Indications, Adverse Effect Management, and Dose Modification Guide
6
Adagrasib (Krazati): A Complete Guide to Side-Effect Recognition and Grade-Based Management
7
Tepotinib (TEPMETKO): Complete Dosing, Side-Effect Management, and Discontinuation Guide
8
Valganciclovir (Valcyte) in Post-Transplant CMV Management: A Comprehensive Guide
9
Tivozanib Dosage and Administration: Standard Dosing, Cycle Schedule, and Hepatic Impairment Adjustments
10
Long-Term Anagrelide Use: Common Adverse Effects and Key Monitoring Considerations
11
Resmetirom Indication Clarification: Approved for NASH Fibrosis, Not Hepatitis B Cirrhosis
12
Vemurafenib: Mechanism of Action and Clinical Role in BRAF V600E–Targeted Therapy